ATOMOXETINE

Basic Information

Item Value
DrugBank ID DB00289
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 92

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
2 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
3 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
4 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
5 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
6 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
7 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
8 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
9 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
10 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
11 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
12 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
13 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
14 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
15 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
16 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
17 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
18 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
19 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
20 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
21 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
22 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
23 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
24 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
25 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
26 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
27 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
28 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
29 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
30 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
31 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
32 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
33 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
34 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
35 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
36 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
37 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
38 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
39 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
40 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
41 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
42 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
43 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
44 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
45 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
46 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
47 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
48 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph
49 attention deficit-hyperactivity disorder TxGNN Knowledge Graph
50 attention deficit hyperactivity disorder, inattentive type TxGNN Knowledge Graph

(Showing top 50 of 92 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search